Skip to main content

Advertisement

SpringerLink
Log in

Small lymphocytic lymphoma infiltrating gastrointestinal tract and mimicking inflammatory bowel disease, successfully treated with acalabrutinib

  • Correspondence
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

No datasets were generated or analysed during the current study.

References

  1. Barcos M, Lane W, Gomez GA, Han T, Freeman A, Preisler H et al (1987) An autopsy study of 1206 acute and chronic leukemias (1958 to 1982). Cancer 60(4):827–837

    Article  CAS  PubMed  Google Scholar 

  2. Bitetto AM, Lamba G, Cadavid G, Shah D, Forlenza T, Rotatori F et al (2011) Colonic perforation secondary to chronic lymphocytic leukemia infiltration without Richter transformation. Leuk Lymphoma 52(5):930–933

    Article  PubMed  Google Scholar 

  3. Brousse N, Solal-Celigny P, Herrera A, Breil P, Molas G, Flejou JF et al (2018) Gastrointestinal Richter’s syndrome. Hum Pathol 16(8):854–857

    Article  Google Scholar 

  4. Pathirana WGW, Chubb SP, Gillett MJ, Vasikaran S (2018) Faecal calprotectin. Clin Biochem Rev 39(3):77–90

    PubMed  PubMed Central  Google Scholar 

  5. Byrd JC, Hillmen P, Ghia P, Kater AP, Chanan-Khan A, Furman RR et al (2019) Acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia: results of the first randomized phase III trial. J Clin Oncol 39(31):3441–3452

    Article  Google Scholar 

  6. Sharman JP, Egyed M, Jurczak W, Skarbnik A, Pagel JM, Flinn IW et al (2020) Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial. Lancet 395(10232):1278–1291

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Burger JA (2019) Bruton tyrosine kinase inhibitors: present and future. Cancer J 25(6):386–393

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, General Hospital of Šibenik-Knin County, Stjepana Radića 83, 22000, Šibenik, Croatia

    Ivan Krečak & Eva Čubrić

  2. Faculty of Medicine, University of Rijeka, Rijeka, Croatia

    Ivan Krečak & Marko Skelin

  3. University of Applied Sciences, Šibenik, Croatia

    Ivan Krečak & Marko Skelin

  4. Department of Pathology and Cytology, General Hospital of Šibenik-Knin County, Šibenik, Croatia

    Jelena Smolić & Branka Vrbičić

  5. Division of Pathology and Cytology, University Hospital Center Split, Split, Croatia

    Ivana Karaman

  6. Pharmacy Department, General Hospital of Šibenik-Knin County, Šibenik, Croatia

    Marko Skelin

Authors
  1. Ivan Krečak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eva Čubrić
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jelena Smolić
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Branka Vrbičić
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ivana Karaman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marko Skelin
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

I. Krečak and E.Č. treated the patient and wrote the first draft of the manuscript. J.S., B.V., and I. Karaman prepared the figures. M.S. wrote the first draft of the manuscript. All authors revised the manuscript and approved its final version.

Corresponding author

Correspondence to Ivan Krečak.

Ethics declarations

Ethics approval

The presented patient provided consent for this report. General Hospital of Šibenik-Knin County does not require ethical approval for reporting case reports or case series.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krečak, I., Čubrić, E., Smolić, J. et al. Small lymphocytic lymphoma infiltrating gastrointestinal tract and mimicking inflammatory bowel disease, successfully treated with acalabrutinib. Ann Hematol 103, 1021–1023 (2024). https://doi.org/10.1007/s00277-023-05585-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05585-9

Search

Navigation